Schouw & Co (SCHO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Q1 2026 delivered a solid start amid geopolitical and macroeconomic uncertainty, with all portfolio businesses performing in line with expectations and earnings increasing despite a 3% revenue decline year-over-year.
EBITDA rose 5% to DKK 591 million and profit before tax increased 36% year-over-year, reflecting strong operational focus, cost optimization, and lower net financial expenses.
Net interest-bearing leverage improved to 1.6x EBITDA, with net interest-bearing debt reduced year-over-year.
Full-year 2026 guidance is maintained despite elevated geopolitical and macroeconomic uncertainty.
The IPO process for BioMar advanced, with an Intention to Float announced and preparations ongoing; proceeds intended to strengthen financial flexibility and support further investments.
Financial highlights
Q1 2026 revenue was DKK 7.7 billion, down 3% year-over-year; EBITDA up 5% to DKK 591 million; profit before tax up 36%.
BioMar revenue down 6% to DKK 3.2 billion, volume up 7% to 315,000 tons; EBITDA up 3%.
GPV revenue down 3% to DKK 2.1 billion; EBITDA up 12% to DKK 160 million; strong order intake and book-to-bill ratio.
HydraSpecma revenue up 9% to DKK 873 million; EBITDA up 5% to DKK 114 million, including a DKK 12 million one-off gain from real estate sale.
Borg Automotive revenue down 12% to DKK 444 million; EBITDA down 58% to DKK 13 million, impacted by restructuring costs.
Fibertex Personal Care revenue down 9% to DKK 404 million; EBITDA down 5% to DKK 47 million.
Fibertex Nonwovens revenue up 10% to DKK 638 million; EBITDA up 48% to DKK 64 million.
Outlook and guidance
Full-year group guidance maintained: revenue DKK 33–35.5 billion, EBITDA DKK 2.9–3.2 billion.
Segment-level guidance unchanged for all portfolio businesses, with expectations of margin-driven earnings growth in several units.
Fibertex businesses may see higher revenue but profit pressure if raw material prices rise.
Latest events from Schouw & Co
- Record cash flow and EBITDA growth in most segments, with improved leverage and strong 2026 outlook.SCHO
Q4 20255 Mar 2026 - EBITDA guidance raised as margin gains offset revenue decline amid market headwinds.SCHO
Q2 20241 Feb 2026 - Revenue and EBITDA fell, but margins and cash flow held; BioMar IPO and cost cuts in focus.SCHO
Q3 202415 Jan 2026 - EBITDA rose 3% to DKK 2.93bn despite a 7% revenue drop, with strong cash flow and lower debt.SCHO
Q4 202423 Dec 2025 - Q1 2025 revenue up 1%, EBITDA down 13%, guidance maintained, BioMar IPO prep advances.SCHO
Q1 202529 Nov 2025 - Stable Q2 with strong cash flow and narrowed guidance; segment outlooks mixed amid volatility.SCHO
Q2 202523 Nov 2025 - EBITDA rose 5% despite a 4% revenue drop, with narrowed guidance and ongoing restructuring.SCHO
Q3 202512 Nov 2025